Avalo Therapeutics, Inc. (AVTX)

14.41 -1.51 (-9.48%) USD  |  NASDAQ  |  Apr 08, 16:00
14.41 0.00 (0.00%) Pre-Market: 08:57
More

Avalo Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade